Ironwood Pharmaceuticals | IRWD - PE Price to Earnings


Ironwood Pharmaceuticals reported 204.24 in PE Price to Earnings for its fiscal quarter ending in December of 2024.





Pe Change Date
Acadia Pharmaceuticals 10.08 1.53 Mar/2026
Agios Pharmaceuticals 3.56 0 Mar/2026
Akebia Therapeutics 1.63K 1.6K Dec/2025
Almirall 79.43 0.3 Dec/2025
Alnylam Pharmaceuticals 80.04 90.66 Mar/2026
Amarin 91.05 88.3 Jun/2023
Astellas Pharma 15.48 8.16 Mar/2026
AstraZeneca 29.59 2.3 Mar/2026
Charles River Laboratories 29.26 14.31 Mar/2026
Emergent BioSolutions 14.4 2.25 Sep/2022
Esperion Therapeutics 129.79 129 Dec/2024
Halozyme Therapeutics 11.35 11.8 Mar/2026
Incyte 15.35 0.51 Mar/2026
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pacira 38.58 14.1 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Sarepta Therapeutics 27.27 0 Dec/2025
Takeda 46.52 188.53 Mar/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023